Cargando…

Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

BACKGROUND: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is the most common presentation of a disorder of sex development (DSD) in genetic females. A report of prenatal growth retardation in cases of 46,XY DSD, coupled with observations of below-optimal final height in both males...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalmers, Laura J, Doherty, Paul, Migeon, Claude J, Copeland, Kenneth C, Bright, Brianna C, Wisniewski, Amy B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113712/
https://www.ncbi.nlm.nih.gov/pubmed/21545705
http://dx.doi.org/10.1186/2042-6410-2-5
_version_ 1782205953330905088
author Chalmers, Laura J
Doherty, Paul
Migeon, Claude J
Copeland, Kenneth C
Bright, Brianna C
Wisniewski, Amy B
author_facet Chalmers, Laura J
Doherty, Paul
Migeon, Claude J
Copeland, Kenneth C
Bright, Brianna C
Wisniewski, Amy B
author_sort Chalmers, Laura J
collection PubMed
description BACKGROUND: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is the most common presentation of a disorder of sex development (DSD) in genetic females. A report of prenatal growth retardation in cases of 46,XY DSD, coupled with observations of below-optimal final height in both males and females with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, prompted us to investigate prenatal growth in the latter group. Additionally, because girls with congenital adrenal hyperplasia are exposed to increased levels of androgens in the absence of a male sex-chromosome complement, the presence or absence of typical sex differences in growth of newborns would support or refute a hormonal explanation for these differences. METHODS: In total, 105 newborns with congenital adrenal hyperplasia were identified in our database. Gestational age (weeks), birth weight (kg), birth length (cm) and parental heights (cm) were obtained. Mid-parental height was considered in the analyses. RESULTS: Mean birth weight percentile for congenital adrenal hyperplasia was 49.26%, indicating no evidence of a difference in birth weight from the expected standard population median of 50th percentile (P > 0.05). The expected sex difference in favor of heavier males was not seen (P > 0.05). Of the 105 subjects, 44 (27%; 34 females, 10 males) had birth length and gestational age recorded in their medical chart. Mean birth length for this subgroup was 50.90 cm (63rd percentile), which differed from the expected standard population median of 50th percentile (P = 0.0082). The expected sex difference in favor of longer males was also not seen (P > 0.05). CONCLUSION: The prenatal growth retardation patterns reported in cases of 46,XY disorders of sex development do not generalize to people with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Sex differences in body weight and length typically seen in young infants were not seen in the subjects who participated in this study. We speculate that these differences were ameliorated in this study because of increased levels of prenatal androgens experienced by the females infants.
format Online
Article
Text
id pubmed-3113712
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31137122011-06-14 Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Chalmers, Laura J Doherty, Paul Migeon, Claude J Copeland, Kenneth C Bright, Brianna C Wisniewski, Amy B Biol Sex Differ Research BACKGROUND: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is the most common presentation of a disorder of sex development (DSD) in genetic females. A report of prenatal growth retardation in cases of 46,XY DSD, coupled with observations of below-optimal final height in both males and females with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, prompted us to investigate prenatal growth in the latter group. Additionally, because girls with congenital adrenal hyperplasia are exposed to increased levels of androgens in the absence of a male sex-chromosome complement, the presence or absence of typical sex differences in growth of newborns would support or refute a hormonal explanation for these differences. METHODS: In total, 105 newborns with congenital adrenal hyperplasia were identified in our database. Gestational age (weeks), birth weight (kg), birth length (cm) and parental heights (cm) were obtained. Mid-parental height was considered in the analyses. RESULTS: Mean birth weight percentile for congenital adrenal hyperplasia was 49.26%, indicating no evidence of a difference in birth weight from the expected standard population median of 50th percentile (P > 0.05). The expected sex difference in favor of heavier males was not seen (P > 0.05). Of the 105 subjects, 44 (27%; 34 females, 10 males) had birth length and gestational age recorded in their medical chart. Mean birth length for this subgroup was 50.90 cm (63rd percentile), which differed from the expected standard population median of 50th percentile (P = 0.0082). The expected sex difference in favor of longer males was also not seen (P > 0.05). CONCLUSION: The prenatal growth retardation patterns reported in cases of 46,XY disorders of sex development do not generalize to people with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Sex differences in body weight and length typically seen in young infants were not seen in the subjects who participated in this study. We speculate that these differences were ameliorated in this study because of increased levels of prenatal androgens experienced by the females infants. BioMed Central 2011-05-05 /pmc/articles/PMC3113712/ /pubmed/21545705 http://dx.doi.org/10.1186/2042-6410-2-5 Text en Copyright ©2011 Chalmers et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Chalmers, Laura J
Doherty, Paul
Migeon, Claude J
Copeland, Kenneth C
Bright, Brianna C
Wisniewski, Amy B
Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
title Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
title_full Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
title_fullStr Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
title_full_unstemmed Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
title_short Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
title_sort normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,xy disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113712/
https://www.ncbi.nlm.nih.gov/pubmed/21545705
http://dx.doi.org/10.1186/2042-6410-2-5
work_keys_str_mv AT chalmerslauraj normalsexdifferencesinprenatalgrowthandabnormalprenatalgrowthretardationassociatedwith46xydisordersofsexdevelopmentareabsentinnewbornswithcongenitaladrenalhyperplasiadueto21hydroxylasedeficiency
AT dohertypaul normalsexdifferencesinprenatalgrowthandabnormalprenatalgrowthretardationassociatedwith46xydisordersofsexdevelopmentareabsentinnewbornswithcongenitaladrenalhyperplasiadueto21hydroxylasedeficiency
AT migeonclaudej normalsexdifferencesinprenatalgrowthandabnormalprenatalgrowthretardationassociatedwith46xydisordersofsexdevelopmentareabsentinnewbornswithcongenitaladrenalhyperplasiadueto21hydroxylasedeficiency
AT copelandkennethc normalsexdifferencesinprenatalgrowthandabnormalprenatalgrowthretardationassociatedwith46xydisordersofsexdevelopmentareabsentinnewbornswithcongenitaladrenalhyperplasiadueto21hydroxylasedeficiency
AT brightbriannac normalsexdifferencesinprenatalgrowthandabnormalprenatalgrowthretardationassociatedwith46xydisordersofsexdevelopmentareabsentinnewbornswithcongenitaladrenalhyperplasiadueto21hydroxylasedeficiency
AT wisniewskiamyb normalsexdifferencesinprenatalgrowthandabnormalprenatalgrowthretardationassociatedwith46xydisordersofsexdevelopmentareabsentinnewbornswithcongenitaladrenalhyperplasiadueto21hydroxylasedeficiency